SynopsisThe global market for Antivenom was estimated to be worth US$ 1041 million in 2024 and is forecast to a readjusted size of US$ 1383 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031. This report provides a comprehensive assessment .....
SynopsisThe global market for Solvent-based Adhesives for Medical Tapes was estimated to be worth US$ 396 million in 2024 and is forecast to a readjusted size of US$ 530 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031. Skin is the larges.....
SynopsisThe global market for Chondroitin Sulfate was estimated to be worth US$ 1245 million in 2024 and is forecast to a readjusted size of US$ 1826 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031. Chondroitin Sulfate is a Sulfated glyc.....
SynopsisThe global market for Oral Proteins and Peptides was estimated to be worth US$ 2346 million in 2024 and is forecast to a readjusted size of US$ 6355 million by 2031 with a CAGR of 15.3% during the forecast period 2025-2031. This report provides a compreh.....
SynopsisThe global market for Continuous Positive Airway Pressure (CPAP) Devices was estimated to be worth US$ 1993 million in 2024 and is forecast to a readjusted size of US$ 3456 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031. Continu.....
SynopsisThe global market for Hemoperfusion was estimated to be worth US$ 697 million in 2024 and is forecast to a readjusted size of US$ 2199 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031. This report provides a comprehensive assessm.....
SynopsisThe global market for CPAP Ventilators was estimated to be worth US$ 2948 million in 2024 and is forecast to a readjusted size of US$ 3890 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031. A continuous positive airway pressure (CP.....
Synopsis The global market for E-Prescribing System was estimated to be worth US$ 3618 million in 2024 and is forecast to a readjusted size of US$ 11686 million by 2031 with a CAGR of 18.3% during the forecast period 2025-2031. E-prescribing or e.....
SynopsisThe global market for Cutaneous Leishmaniasis Drugs was estimated to be worth US$ 46.6 million in 2024 and is forecast to a readjusted size of US$ 61.4 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031. Cutaneous leishmaniasis is t.....
SynopsisThe global market for Microbiome Drugs was estimated to be worth US$ 568 million in 2024 and is forecast to a readjusted size of US$ 3296 million by 2031 with a CAGR of 30.1% during the forecast period 2025-2031. Microbiome Drugs refer to a new class of .....
